LJI Wealth Management’s Xeris Biopharma Holdings XERS Stock Holding History

LJI Wealth Management’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-42,350	Closed	-$332K	–	206
2025 Q4	$332K	Hold	42,350	–	–	0.05%	145
2025 Q3	$345K	Hold	42,350	–	–	0.06%	120
2025 Q2	$198K	Hold	42,350	–	–	0.03%	178
2025 Q1	$233K	Hold	42,350	–	–	0.05%	160
2024 Q4	$144K	Sell	42,350 -5,700	-12%	-$18.3K	0.03%	175
2024 Q3	$137K	Hold	48,050	–	–	0.03%	187
2024 Q2	$108K	Sell	48,050 -3,400	-7%	-$6.85K	0.02%	179
2024 Q1	$114K	Sell	51,450 -4,600	-8%	-$11.9K	0.03%	147
2023 Q4	$132K	Sell	56,050 -5,300	-9%	-$9.78K	0.03%	164
2023 Q3	$114K	Sell	61,350 -9,600	-14%	-$22K	0.03%	157
2023 Q2	$186K	Sell	70,950 -5,200	-7%	-$13.2K	0.05%	152
2023 Q1	$124K	Sell	76,150 -31,800	-29%	-$39.8K	0.04%	152
2022 Q4	$144K	Buy	+107,950	New	+$152K	0.05%	143

Other funds holding XERS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LJI Wealth Management's XERS Position: Q1 2026 in Review

LJI Wealth Management sold out of Xeris Biopharma Holdings (XERS) in Q1 2026, closing a stake of 42,350 shares — an estimated $332K sold.

LJI Wealth Management first reported a position in XERS in Q4 2022 and held it in 13 quarters. The position peaked at $345K in Q3 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

LJI Wealth Management reported no remaining Xeris Biopharma Holdings position as of Q1 2026 after selling out during the quarter.
LJI Wealth Management sold 42,350 Xeris Biopharma Holdings shares in Q1 2026, an estimated $332K.
LJI Wealth Management first reported a position in Xeris Biopharma Holdings in Q4 2022 and held it in 13 quarters.
LJI Wealth Management's Xeris Biopharma Holdings position peaked at $345K in Q3 2025.
237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on LJI Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.